September 18, 2012
The Question Every Healthcare IT Startup Must Answer
When I started in the healthcare field more than 25 years ago, the only thing that a healthcare IT startup needed was a good idea — a new technology, maybe,…
Posted by
Safeguard Insights
September 18, 2012
Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals
For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…
Posted by
Aggregate Partner Company Revenue up 73% in Q3; Guidance Increased to between $360 Million to $385 Million
Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…
Posted by
Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market
On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…
Posted by
New York Times puts Avid’s Technology Front and Center
Avid Radiopharmaceuticals was featured on the front page of The New York Times today. The article, “Promise Seen for Detection of Alzheimer’s,” by Gina Kolata (@ginakolata), highlights…
Posted by
Diagnostic Imaging Continues to Garner Investor Interest
On the heels of the BIO International Convention, I came across this piece by FierceBiotech’s Maureen Martino highlighting a panel of biotech VCs who made…
Posted by
Avid Radiopharmaceuticals Announces Positive Interim Results from Phase III Clinical Trial of Amyloid Imaging Agent Florbetapir F18
Our partner company, Avid Radiopharmaceuticals, announced positive interim results from the Phase III clinical trial of its amyloid imaging agent Florbetapir F18 for early diagnosis…
Posted by
Fourth Quarter and Fiscal 2009 Financial Disclosures Articulate 2010 Opportunities and Objectives
In our report for the period ended Dec. 31, 2009 that was released this morning, we updated investors on the significant progress achieved by Safeguard…
Posted by
Avid Radiopharmaceuticals Presents at J.P. Morgan Investor Conference
Safeguard Scientifics’ partner company Avid Radiopharmaceuticals was invited to present its technology and growth strategy at the prestigious J.P. Morgan 28th Annual Healthcare Conference in…
Posted by
